Zhuhai Rundu Pharmaceutical Co., Ltd. (SHE:002923)
China · Delayed Price · Currency is CNY 15.67
+0.24 (1.56%)
At close: Feb 27, 2026
SHE:002923 Revenue
Zhuhai Rundu Pharmaceutical had revenue of 336.33M CNY in the quarter ending September 30, 2025, with 20.20% growth. This brings the company's revenue in the last twelve months to 1.19B, down -2.76% year-over-year. In the year 2024, Zhuhai Rundu Pharmaceutical had annual revenue of 1.18B, down -8.48%.
Revenue (ttm)
1.19B
Revenue Growth
-2.76%
P/S Ratio
4.41
Revenue / Employee
599.38K
Employees
1,985
Market Cap
5.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.18B | -109.52M | -8.48% |
| Dec 31, 2023 | 1.29B | -80.35M | -5.86% |
| Jan 1, 2023 | 1.37B | 182.31M | 15.32% |
| Jan 1, 2022 | 1.19B | -62.70M | -5.01% |
| Dec 31, 2020 | 1.25B | -107.28M | -7.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jianmin Pharmaceutical Group | 3.18B |
| Luoxin Pharmaceuticals Group Stock | 2.49B |
| Fuan Pharmaceutical (Group) | 1.71B |
| Bide Pharmatech | 1.27B |
| Newland Pharmaceutical | 670.43M |
| Zhongzhu Healthcare Holding Co.,Ltd | 570.62M |
| Hubei Biocause Heilen Pharmaceutical | 430.77M |
| Zhejiang Yatai Pharmaceutical | 326.64M |